Skip to main content

Table 3 Hazard ratios for prevalence of cfPWV, Mets and its components with an elevation in serum ALT levels

From: The relationship of serum alanine aminotransferase normal-range levels to arterial stiffness and metabolic syndrome in non-drinkers and drinkers: a Chinese community-based analysis

Serum ALT levels Non-drinkers Drinkers
HR (95% CI) P-value HR (95% CI) P-value
Mets ≤10 U/L 1   1  
11-20 U/L 3.443(2.160-5.487) <0.001 4.515(1.373-14.851) <0.001
21-30 U/L 6.312(3.859-10.324) <0.001 7.500(2.249-25.011) <0.001
31-40 U/L 7.786(4.331-13.996) <0.001 14.318(4.125-49.699) <0.001
Central obesity ≤10 U/L 1   1  
11-20 U/L 3.300(2.377-4.579) <0.001 2.789(1.548-5.026) 0.001
21-30 U/L 5.294(3.623-7.734) <0.001 4.926(2.610-9.296) <0.001
31-40 U/L 6.202(3.649-10.539) <0.001 6.778(3.165-14.512) <0.001
High TG ≤10 U/L 1   1  
11-20 U/L 3.493(2.228-5.475) <0.001 4.950(1.746-14.035) 0.003
21-30 U/L 5.721(3.550-9.220) <0.001 12.560(4.369-36.107) <0.001
31-40 U/L 7.621(4.292-13.532) <0.001 17.537(5.782-53.191) <0.001
Low HDL-c ≤10 U/L 1   1  
11-20 U/L 1.152(0.808-1.643) 0.435 7.700(1.040-57.029) 0.046
21-30 U/L 1.415(0.953-2.101) 0.085 12.895(1.726-96.357) 0.013
31-40 U/L 1.631(0.973-2.735) 0.063 16.525(2.136-127.859) 0.007
High blood pressure ≤10 U/L 1   1  
11-20 U/L 2.355(1.688-3.285) <0.001 1.710(0.914-3.199) 0.093
21-30 U/L 2.969(1.815-4.858) <0.001 1.960(1.016-3.783) 0.045
31-40 U/L 3.955(2.716-5.758) <0.001 2.227(1.065-4.659) 0.033
High blood glucose ≤10 U/L 1   1  
11-20 U/L 2.524(1.564-4.075) <0.001 1.284(0.484-3.403) 0.615
21-30 U/L 2.841(1.699-4.753) <0.001 1.605(0.585-4.405) 0.358
31-40 U/L 3.296(1.768-6.145) <0.001 2.852(0.985-8.256) 0.053
cfPWV > 10 m/s ≤10 U/L 1   1  
11-20 U/L 2.481(1.795-3.429) <0.001 1.437(0.808-2.558) 0.217
21-30 U/L 3.405(2.358-4.918) <0.001 0.980(0.530-1.812) 0.948
31-40 U/L 2.279(1.403-3.701) 0.001 1.364(0.679-2.740) 0.384
  1. Abbreviations: cfPWV carotid-femoral pulse wave velocity, Mets metabolic syndrome, ALT alanine aminotransferase, HR hazard ratio, CI confidential interval, TG triglyceride, HDL-c high-density lipoprotein-cholesterol